283 related articles for article (PubMed ID: 31498806)
41. Detection of PLA2R Autoantibodies before the Diagnosis of Membranous Nephropathy.
Burbelo PD; Joshi M; Chaturvedi A; Little DJ; Thurlow JS; Waldman M; Olson SW
J Am Soc Nephrol; 2020 Jan; 31(1):208-217. PubMed ID: 31843984
[TBL] [Abstract][Full Text] [Related]
42. Tacrolimus combined with corticosteroids versus Modified Ponticelli regimen in treatment of idiopathic membranous nephropathy: Randomized control trial.
Ramachandran R; Hn HK; Kumar V; Nada R; Yadav AK; Goyal A; Kumar V; Rathi M; Jha V; Gupta KL; Sakhuja V; Kohli HS
Nephrology (Carlton); 2016 Feb; 21(2):139-46. PubMed ID: 26205759
[TBL] [Abstract][Full Text] [Related]
43. Evolution of antibody titre against the M-type phospholipase A2 receptor and clinical response in idiopathic membranous nephropathy patients treated with tacrolimus.
Segarra-Medrano A; Jatem-Escalante E; Carnicer-Cáceres C; Agraz-Pamplona I; Salcedo MT; Valtierra N; Ostos-Roldán E; Arredondo KV; Jaramillo J
Nefrologia; 2014; 34(4):491-7. PubMed ID: 25036063
[TBL] [Abstract][Full Text] [Related]
44. Prognostic value of the dynamics of M-type phospholipase A2 receptor antibody titers in patients with idiopathic membranous nephropathy treated with two different immunosuppression regimens.
Medrano AS; Escalante EJ; Cáceres CC; Pamplona IA; Allende MT; Terrades NR; Carmeno NV; Roldán EO; Agudelo KV; Vasquez JJ
Biomarkers; 2015 Feb; 20(1):77-83. PubMed ID: 25519165
[TBL] [Abstract][Full Text] [Related]
45. [Membranous glomerulonephritis : An example of individualized medicine in nephrology].
Stahl RAK; Hoxha E
Internist (Berl); 2019 May; 60(5):440-449. PubMed ID: 30859275
[TBL] [Abstract][Full Text] [Related]
46. [Membranous glomerulonephritis: better therapy with autoantibody monitoring?].
Stahl RA; Hoxha E; Helmchen U
Dtsch Med Wochenschr; 2011 Aug; 136(34-35):1733-7. PubMed ID: 21877306
[TBL] [Abstract][Full Text] [Related]
47. Primary membranous nephropathy in adolescence: A prospective study.
Kumar V; Varma AK; Nada R; Ghosh R; Suri D; Gupta A; Kumar V; Rathi M; Kohli H; Jha V; Gupta K; Ramachandran R
Nephrology (Carlton); 2017 Sep; 22(9):678-683. PubMed ID: 27334445
[TBL] [Abstract][Full Text] [Related]
48. Serum Levels of BAFF and APRIL Predict Clinical Response in Anti-PLA2R-Positive Primary Membranous Nephropathy.
Netti GS; Infante B; Spadaccino F; Godeas G; Corallo MG; Prisciandaro C; Croce L; Rotondi M; Gesualdo L; Stallone G; Grandaliano G; Ranieri E
J Immunol Res; 2019; 2019():8483650. PubMed ID: 31781684
[TBL] [Abstract][Full Text] [Related]
49. Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy.
Segarra-Medrano A; Jatem-Escalante E; Quiles-Pérez MT; Salcedo MT; Arbós-Via MA; Ostos H; Valtierra N; Carnicer-Cáceres C; Agraz-Pamplona I
Nefrologia; 2014 May; 34(3):353-9. PubMed ID: 24798555
[TBL] [Abstract][Full Text] [Related]
50. Preparation of an epitope-based recombinant diagnostic antigen specific to anti-phospholipase A
Li H; Xu Y; Yang W; Huang X
BMC Biotechnol; 2018 May; 18(1):31. PubMed ID: 29843797
[TBL] [Abstract][Full Text] [Related]
51. An immunofluorescence test for phospholipase-A₂-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis.
Hoxha E; Harendza S; Zahner G; Panzer U; Steinmetz O; Fechner K; Helmchen U; Stahl RA
Nephrol Dial Transplant; 2011 Aug; 26(8):2526-32. PubMed ID: 21633097
[TBL] [Abstract][Full Text] [Related]
52. [Idiopathic and secondary membranous nephropathies].
Ronco P; Debiec H
Presse Med; 2012 Mar; 41(3 Pt 1):290-7. PubMed ID: 22208961
[TBL] [Abstract][Full Text] [Related]
53. Anti-PLA2R1 Antibodies as Prognostic Biomarker in Membranous Nephropathy.
Logt AV; Justino J; Vink CH; van den Brand J; Debiec H; Lambeau G; Wetzels JF
Kidney Int Rep; 2021 Jun; 6(6):1677-1686. PubMed ID: 34169209
[TBL] [Abstract][Full Text] [Related]
54. Cross-reactivity of anti-PLA2R1 autoantibodies to rabbit and mouse PLA2R1 antigens and development of two novel ELISAs with different diagnostic performances in idiopathic membranous nephropathy.
Seitz-Polski B; Dolla G; Payré C; Tomas NM; Lochouarn M; Jeammet L; Mariat C; Krummel T; Burtey S; Courivaud C; Schlumberger W; Zorzi K; Benzaken S; Bernard G; Esnault VL; Lambeau G
Biochimie; 2015 Nov; 118():104-15. PubMed ID: 26296473
[TBL] [Abstract][Full Text] [Related]
55. Serum anti-phospholipase A2 receptor (PLA2R) antibody detected at diagnosis as a predictor for clinical remission in patients with primary membranous nephropathy: a meta-analysis.
Liang Y; Wan J; Chen Y; Pan Y
BMC Nephrol; 2019 Sep; 20(1):360. PubMed ID: 31533641
[TBL] [Abstract][Full Text] [Related]
56. Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy.
Dähnrich C; Komorowski L; Probst C; Seitz-Polski B; Esnault V; Wetzels JF; Hofstra JM; Hoxha E; Stahl RA; Lambeau G; Stöcker W; Schlumberger W
Clin Chim Acta; 2013 Jun; 421():213-8. PubMed ID: 23541686
[TBL] [Abstract][Full Text] [Related]
57. Serum Anti-PLA2R Antibody Predicts Treatment Outcome in Idiopathic Membranous Nephropathy.
Wei SY; Wang YX; Li JS; Zhao SL; Diao TT; Wang Y; Wang C; Qin Y; Cao Y; Wei Q; Li B
Am J Nephrol; 2016; 43(2):129-40. PubMed ID: 27058841
[TBL] [Abstract][Full Text] [Related]
58. Clinicopathological Features of Idiopathic Membranous Nephropathy in 33 Adolescents.
Li C; Li H; Wen YB; Li JN; Lin WF; Cai JF; Duan L; Li Y; Li XM; Li XW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):544-551. PubMed ID: 28877834
[TBL] [Abstract][Full Text] [Related]
59. Antiphospholipase A2 Receptor Antibody Levels Predict the Risk of Posttransplantation Recurrence of Membranous Nephropathy.
Quintana LF; Blasco M; Seras M; Pérez NS; López-Hoyos M; Villarroel P; Rodrigo E; Viñas O; Ercilla G; Diekmann F; Gómez-Roman JJ; Fernandez-Fresnedo G; Oppenheimer F; Arias M; Campistol JM
Transplantation; 2015 Aug; 99(8):1709-14. PubMed ID: 25675198
[TBL] [Abstract][Full Text] [Related]
60. [Membranous nephropathy: New insights in therapeutic approach].
Dahan K
Nephrol Ther; 2017 Apr; 13 Suppl 1():S83-S87. PubMed ID: 28577748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
